Evidence map›Paper›PMID 25241746›Full record

ArticleStem cell reports2014

Tracing the origin of the HSC hierarchy reveals an SCF-dependent, IL-3-independent CD43(-) embryonic precursor.

Stanislav Rybtsov, Antoniana Batsivari, Kateryna Bilotkach, Daria Paruzina, Jordi Senserrich, Oleg Nerushev, Alexander Medvinsky

Open access · goldAbstract read
In one paragraph

Article in Stem cell reports, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 100 papers.

0numbers the graph read from it
0cells of the map it votes in
100citing papers in PubMed
5.2field-weighted citation impact, top 4% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

100 citing papers in PubMed, 158 citations in OpenAlex.

  1. Article
  2. Article
  3. Review
  4. Article
  5. Article
  6. Review
  7. Article
  8. Article
  9. Review
  10. Review
  11. Article
  12. Review
  13. Transition of signal requirement in hematopoietic stem cell development from hemogenic endothelial cells.Proceedings of the National Academy of Sciences of the United States of America · 2024
    Article
  14. Article
  15. Article
  16. Article
  17. Review
  18. The evolving hematopoietic niche during development.Frontiers in molecular biosciences · 2024
    Review
  19. Article
  20. Article

40 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 2 institutions in 1 country.

Stanislav RybtsovMRC Centre for Regenerative Medicine, The University of Edinburgh, Edinburgh EH16 4UU, Scotland, UK.
Antoniana BatsivariMRC Centre for Regenerative Medicine, The University of Edinburgh, Edinburgh EH16 4UU, Scotland, UK.
Kateryna BilotkachMRC Centre for Regenerative Medicine, The University of Edinburgh, Edinburgh EH16 4UU, Scotland, UK.
Daria ParuzinaMRC Centre for Regenerative Medicine, The University of Edinburgh, Edinburgh EH16 4UU, Scotland, UK.
Jordi SenserrichMRC Centre for Regenerative Medicine, The University of Edinburgh, Edinburgh EH16 4UU, Scotland, UK.
Oleg NerushevSchool of Chemistry, EaStCHEM, The University of Edinburgh, Edinburgh EH9 3JJ, Scotland, UK.
Alexander MedvinskyMRC Centre for Regenerative Medicine, The University of Edinburgh, Edinburgh EH16 4UU, Scotland, UK. Electronic address: a.medvinsky@ed.ac.uk.
University of Edinburgh · GBMRC Centre for Regenerative Medicine · GB

Funding

Biotechnology and Biological Sciences Research Council BB/D01347X/1Biotechnology and Biological Sciences Research Council BB/H008780/1Medical Research Council G0500950Medical Research Council G0900962Wellcome Trust
6 · The paper itself

Abstract

Definitive hematopoietic stem cells (HSCs) develop in the aorta gonad mesonephros (AGM) region in a stepwise manner. Type I pre-HSCs express CD41 but lack CD45 expression, which is subsequently upregulated in type II pre-HSCs prior to their maturation into definitive HSCs. Here, using ex vivo modeling of HSC development, we identify precursors of definitive HSCs in the trunk of the embryonic day 9.5 (E9.5) mouse embryo. These precursors, termed here pro-HSCs, are less mature than type I and II pre-HSCs. Although pro-HSCs are CD41(+), they lack the CD43 marker, which is gradually upregulated in the developing HSC lineage. We show that stem cell factor (SCF), but not interleukin-3 (IL-3), is a major effector of HSC maturation during E9-E10. This study extends further the previously established hierarchical organization of the developing HSC lineage and presents it as a differentially regulated four-step process and identifies additional targets that could facilitate the generation of transplantable HSCs from pluripotent cells for clinical needs.

Indexed as

HematopoiesisAnimalsAortaCell LineageEmbryo, MammalianGene DeletionHematopoietic Stem CellsInterleukin-3LeukosialinMesonephrosMiceMice, Inbred C57BLStem Cell FactorInterleukin-3LeukosialinStem Cell Factor

Identifiers

PMID25241746
PMCPMC4266012
OpenAlexW2131827027

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.